PSMB9 expression was relatively higher in brain cancer, head and neck cancer, bile duct cancer, kidney cancer, leukemia, lymphoma, and myeloma, among which lymphoma showed the highest expression (Figure S2). Here, PSMB9 is linked to plasma cell myeloma.